Perfluorocarbon Nanodroplets as Potential Nanocarriers for Brain Delivery Assisted by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption

The management of brain diseases remains a challenge, particularly because of the difficulty for drugs to cross the blood-brain barrier. Among strategies developed to improve drug delivery, nano-sized emulsions (i.e., nanoemulsions), employed as nanocarriers, have been described. Moreover, focused u...

Full description

Saved in:
Bibliographic Details
Main Authors: Charlotte Bérard (Author), Stéphane Desgranges (Author), Noé Dumas (Author), Anthony Novell (Author), Benoit Larrat (Author), Mourad Hamimed (Author), Nicolas Taulier (Author), Marie-Anne Estève (Author), Florian Correard (Author), Christiane Contino-Pépin (Author)
Format: Book
Published: MDPI AG, 2022-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_47fe15a5d2e34e3db4a06336a18d74b6
042 |a dc 
100 1 0 |a Charlotte Bérard  |e author 
700 1 0 |a Stéphane Desgranges  |e author 
700 1 0 |a Noé Dumas  |e author 
700 1 0 |a Anthony Novell  |e author 
700 1 0 |a Benoit Larrat  |e author 
700 1 0 |a Mourad Hamimed  |e author 
700 1 0 |a Nicolas Taulier  |e author 
700 1 0 |a Marie-Anne Estève  |e author 
700 1 0 |a Florian Correard  |e author 
700 1 0 |a Christiane Contino-Pépin  |e author 
245 0 0 |a Perfluorocarbon Nanodroplets as Potential Nanocarriers for Brain Delivery Assisted by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption 
260 |b MDPI AG,   |c 2022-07-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics14071498 
500 |a 1999-4923 
520 |a The management of brain diseases remains a challenge, particularly because of the difficulty for drugs to cross the blood-brain barrier. Among strategies developed to improve drug delivery, nano-sized emulsions (i.e., nanoemulsions), employed as nanocarriers, have been described. Moreover, focused ultrasound-mediated blood-brain barrier disruption using microbubbles is an attractive method to overcome this barrier, showing promising results in clinical trials. Therefore, nanoemulsions combined with this technology represent a real opportunity to bypass the constraints imposed by the blood-brain barrier and improve the treatment of brain diseases. In this work, a stable freeze-dried emulsion of perfluorooctyl bromide nanodroplets stabilized with home-made fluorinated surfactants able to carry hydrophobic agents is developed. This formulation is biocompatible and droplets composing the emulsion are internalized in multiple cell lines. After intravenous administration in mice, droplets are eliminated from the bloodstream in 24 h (blood half-life (t<sub>1/2</sub>) = 3.11 h) and no long-term toxicity is expected since they are completely excreted from mice' bodies after 72 h. In addition, intracerebral accumulation of tagged droplets is safely and significantly increased after focused ultrasound-mediated blood-brain barrier disruption. Thus, the proposed nanoemulsion appears as a promising nanocarrier for a successful focused ultrasound-mediated brain delivery of hydrophobic agents. 
546 |a EN 
690 |a nanoemulsions 
690 |a droplets 
690 |a brain diseases 
690 |a blood-brain barrier 
690 |a ultrasound 
690 |a drug carrier 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 14, Iss 7, p 1498 (2022) 
787 0 |n https://www.mdpi.com/1999-4923/14/7/1498 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/47fe15a5d2e34e3db4a06336a18d74b6  |z Connect to this object online.